Literature DB >> 29446065

Simulating Variation in Families' Spending across Marketplace Plans.

Yuting Zhang1, Seo Hyon Baik2, Samuel H Zuvekas3.   

Abstract

OBJECTIVE: To examine variations in premium and cost-sharing across marketplace plans available to eligible families. DATA SOURCES: 2011-2012 Medical Expenditure Panel Survey (MEPS), 2014 health plan data from healthcare.gov, and the 2011 Medicare Part D public formulary file. STUDY
DESIGN: We identified a nationally representative cohort of individuals in the MEPS who would have been eligible for marketplace coverage. For each family, we simulated the total out-of-pocket payment (premium plus cost-sharing) under each available plan in their county of residence, assuming their premarketplace use. DATA COLLECTION/EXTRACTION
METHODS: Confidential state and county of residence identifiers were merged onto MEPS public use files and used to match MEPS families to the plans available in their county as reported in the publicly available data from healthcare.gov. PRINCIPAL
FINDINGS: We found substantial variation in total family health care spending, especially premium component, across marketplace plans. This is true even within a plan tier of the same minimum actuarial value, and for families eligible for subsidies. Variation among families with income below 250 percent of the FPL is larger than variation among families with higher income.
CONCLUSIONS: Our simulations show substantial variations in net premium and out-of-pocket payments across marketplace plans, even within a plan tier. © Health Research and Educational Trust.

Keywords:  Health insurance exchanges; health insurance marketplace; simulation

Mesh:

Year:  2018        PMID: 29446065      PMCID: PMC6051972          DOI: 10.1111/1475-6773.12831

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  12 in total

1.  A note on robust variance estimation for cluster-correlated data.

Authors:  R L Williams
Journal:  Biometrics       Date:  2000-06       Impact factor: 2.571

Review 2.  National Health Spending In 2014: Faster Growth Driven By Coverage Expansion And Prescription Drug Spending.

Authors:  Anne B Martin; Micah Hartman; Joseph Benson; Aaron Catlin
Journal:  Health Aff (Millwood)       Date:  2015-12-02       Impact factor: 6.301

3.  Choosing a Health Insurance Plan: Complexity and Consequences.

Authors:  Saurabh Bhargava; George Loewenstein
Journal:  JAMA       Date:  2015-12-15       Impact factor: 56.272

4.  Comparing employer-sponsored and federal exchange plans: wide variations in cost sharing for prescription drugs.

Authors:  Christine Buttorff; Martin S Andersen; Kevin R Riggs; G Caleb Alexander
Journal:  Health Aff (Millwood)       Date:  2015-03       Impact factor: 6.301

Review 5.  Adjusting Health Expenditures for Inflation: A Review of Measures for Health Services Research in the United States.

Authors:  Abe Dunn; Scott D Grosse; Samuel H Zuvekas
Journal:  Health Serv Res       Date:  2016-11-21       Impact factor: 3.402

6.  The ACA’s Cost-Sharing Reduction Plans: A Key to Affordable Health Coverage for Millions of U.S. Workers.

Authors:  Jon Gabel; Heidi Whitmore; Matthew Green; Adrienne Call; Sam Stromberg; Rebecca Oran
Journal:  Issue Brief (Commonw Fund)       Date:  2016-10

7.  Sinking, Swimming, or Learning to Swim in Medicare Part D.

Authors:  Jonathan D Ketcham; Claudio Lucarelli; Eugenio J Miravete; M Christopher Roebuck
Journal:  Am Econ Rev       Date:  2012-10

8.  Many families may face sharply higher costs if public health insurance for their children is rolled back.

Authors:  Thomas M Selden; Lisa Dubay; G Edward Miller; Jessica Vistnes; Matthew Buettgens; Genevieve M Kenney
Journal:  Health Aff (Millwood)       Date:  2015-04       Impact factor: 6.301

9.  Integrating risk adjustment and enrollee premiums in health plan payment.

Authors:  Thomas G McGuire; Jacob Glazer; Joseph P Newhouse; Sharon-Lise Normand; Julie Shi; Anna D Sinaiko; Samuel H Zuvekas
Journal:  J Health Econ       Date:  2013-12       Impact factor: 3.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.